Melanoma Specialist Named ASCO President 2023-2024

December 21, 2021

1 min read

We have not been able to process your request. Please try again later. If you continue to experience this problem, please contact [email protected]

Lynn M. Schuchter, MD, FASCO, was elected ASCO President for the 2023-2024 term.

Schuchter, chief of the hematology-oncology division at the Perelman School of Medicine at the University of Pennsylvania, will serve as president-elect for a one-year term beginning in June 2022. She will serve as president of the ASCO in June 2023.

Lynn M. Schuchter, MD, FASCO

Lynn schuchter

“It is a privilege and an honor to have the opportunity to lead and collaborate with my colleagues as President of ASCO,” Schuchter said in a press release. “We have a lot to celebrate through the dedicated efforts of our colleagues who work every day in the clinic, in hospitals, and through research efforts to improve the lives of people with cancer and prevent more people from developing cancer. Together, in the years to come, we stand ready to make further progress in areas such as equity in cancer care, improving access to care, and rapid dissemination and application of new knowledge and treatments; and innovation to deliver the best possible care to more patients in more ways and settings than ever before.

Schuchter, recognized for her expertise in melanoma, is also director of the Tara Miller Melanoma Center at the Abramson Cancer Center. She was Head of the Hematology-Oncology Division at Penn for 15 years.

Comments are closed.